Effects of bariatric surgery on untreated lower urinary tract symptoms: A prospective multicentre cohort study

BJU International

Volumn 115, Issue 3, 2015, Pages 466-472

  Luke, Serge ^a   Addison, Ben ^b   Broughton, Katherine ^c   Masters, Jonathan ^b   Stubbs, Richard ^d   Kennedy Smith, Andrew ^e  

^a DUNEDIN HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c MIDDLEMORE HOSPITAL   (New Zealand)

^d Wakefield Hospital   (New Zealand)

^e WELLINGTON HOSPITAL   (New Zealand)

Author keywords

bariatric surgery; LUTS; metabolic syndrome

Indexed keywords

GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; BRISTOL FEMALE LOWER URINARY TRACT SYMPTOMS SCORE QUESTIONNAIRE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SLEEVE GASTRECTOMY; STOMACH BYPASS; URINARY TRACT DISEASE ASSESSMENT; WEIGHT REDUCTION; BLOOD; CLINICAL TRIAL; GLUCOSE BLOOD LEVEL; LOWER URINARY TRACT SYMPTOMS; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; TREATMENT OUTCOME;

ADULT; BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; HUMANS; INSULIN; LOWER URINARY TRACT SYMPTOMS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84923056273     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12943     Document Type: Article

References (35)

1. New Zealand Government Ministry of Health. A Focus on Nutrition: Key Findings of the 2008/09 New Zealand Adult Nutrition Survey. Wellington, NZ: Ministry of Health, 2011. Available at: http://www.health.govt.nz/publication/focus-nutrition-key-findings-2008-09-nz-adult-nutrition-survey. Accessed September 2014
2. Ogden CL, Carroll MD, Kit BK, Flegal KM,. Prevalence of obesity among adults: United States, 2011-2012. NCHS Data Brief 2013; 131: 1-8
3. Moul S, McVary KT,. Lower urinary tract symptoms, obesity and the metabolic syndrome. Curr Opin Urol 2010; 20: 7-12
4. Osborn DJ, Strain M, Gomelsky A, Rothschild J, Dmochowski R,. Obesity and female stress urinary incontinence. Urology 2013; 82: 759-763
5. Parsons JK, Sarma AV, McVary K, Wei JT,. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol 2013; 189 (Suppl.): S102-106
6. Mondul AM, Giovannucci E, Platz EA,. A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms. J Urol 2014; 191: 715-721
7. Kupelian V, McVary KT, Kaplan SA, et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey. J Urol 2013; 189 (Suppl.): S107-116
8. Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009; 360: 481-490
9. Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS,. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg 2005; 15: 474-481
10. Carlin AM, Zeni TM, English WJ, et al. The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity. Ann Surg 2013; 257: 791-797
11. Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P,. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 1996; 77: 805-812
12. Barry MJ, Fowler FJ, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-1557
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
14. Muniyappa R, Lee S, Chen H, Quon MJ,. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294: E15-26
15. Kristal AR, Arnold KB, Schenk JM, et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 2007; 177: 1395-1400
16. Penson DF, Munro HM, Signorello LB, Blot WJ, Fowke JH,. Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study. J Urol 2011; 186: 2316-2322
17. Whitcomb EL, Subak LL,. Effect of weight loss on urinary incontinence in women. Open Access J Urol 2011; 3: 123-132
18. Burgio KL, Richter HE, Clements RH, Redden DT, Goode PS,. Changes in urinary and fecal incontinence symptoms with weight loss surgery in morbidly obese women. Obstet Gynecol 2007; 110: 1034-1040
19. Subak LL, Johnson C, Whitcomb E, Boban D, Saxton J, Brown JS,. Does weight loss improve incontinence in moderately obese women? Int Urogynecol J Pelvic Floor Dysfunct 2002; 13: 40-43
20. Hunskaar S,. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn 2008; 27: 749-757
21. Krieger J, Laks L, Wilcox I, et al. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure. Clin Sci 1989; 77: 407-411
22. Kaplan SA,. Metabolic dysfunction and male pelvic health. Eur Urol 2007; 52: 316-317
23. Muller RL, Gerber L, Moreira DM, et al. Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasteride. Eur Urol 2013; 63: 1115-1121
24. Haffner S, Taegtmeyer H,. Epidemic obesity and the metabolic syndrome. Circulation 2003; 108: 1541-1545
25. Rohrmann S, Smit E, Giovannucci E, Platz EA,. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) 2005; 29: 310-316
26. Dahle SE, Chokkalingam AP, Gao Y, Deng J, Stanczyk FZ, Hsing AW,. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002; 168: 599-604
27. Hammarsten J, Högstedt B,. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001; 39: 151-158
28. Giovannucci E, Rimm EB, Chute CG, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 1994; 140: 989-1002
29. Muntzel MS, Anderson EA, Johnson AK, Mark AL,. Mechanisms of insulin action on sympathetic nerve activity. Clin Exp Hypertens 1995; 17: 39-50
30. Zhou M, Schulman IH, Zeng Q,. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease. Vasc Med 2012; 17: 330-341
31. Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S,. Diabetic bladder dysfunction: current translational knowledge. J Urol 2009; 182 (Suppl.): S18-26
32. Umlauf MG, Chasens ER, Greevy RA, Arnold J, Burgio KL, Pillion DJ,. Obstructive sleep apnea, nocturia and polyuria in older adults. Sleep 2004; 27: 139-144
33. Dhabuwala A, Cannan RJ, Stubbs RS,. Improvement in co-morbidities following weight loss from gastric bypass surgery. Obes Surg 2000; 10: 428-435
34. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S,. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235
35. Ranasinghe WK, Wright T, Attia J, et al. Effects of bariatric surgery on urinary and sexual function. BJU Int 2011; 107: 88-94